249 related articles for article (PubMed ID: 28797488)
1. Cryptococcal Lung Infections.
Skolnik K; Huston S; Mody CH
Clin Chest Med; 2017 Sep; 38(3):451-464. PubMed ID: 28797488
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary cryptococcosis: A review of pathobiology and clinical aspects.
Setianingrum F; Rautemaa-Richardson R; Denning DW
Med Mycol; 2019 Feb; 57(2):133-150. PubMed ID: 30329097
[TBL] [Abstract][Full Text] [Related]
3. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary cryptococcosis.
Brizendine KD; Baddley JW; Pappas PG
Semin Respir Crit Care Med; 2011 Dec; 32(6):727-34. PubMed ID: 22167400
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
6. Equine Pulmonary Cryptococcosis: A Comparative Literature Review and Evaluation of Fluconazole Monotherapy.
Secombe CJ; Lester GD; Krockenberger MB
Mycopathologia; 2017 Apr; 182(3-4):413-423. PubMed ID: 27655152
[TBL] [Abstract][Full Text] [Related]
7. [Multiple facial nodules revealing disseminated cryptococcosis in an immunocompetent patient].
Rachadi H; Senouci K; Lyagoubi M; Benzekri A; Mansouri S; Ramli I; Ismaili N; Hassam B; Benzekri L
Ann Dermatol Venereol; 2016 Apr; 143(4):289-94. PubMed ID: 26971369
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system infection due to Cryptococcus gattii sensu lato in India: Analysis of clinical features, molecular profile and antifungal susceptibility.
Lahiri Mukhopadhyay S; Bahubali VH; Manjunath N; Swaminathan A; Maji S; Palaniappan M; Parthasarathy S; Chandrashekar N
Mycoses; 2017 Nov; 60(11):749-757. PubMed ID: 28736880
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcosis.
Negroni R
Clin Dermatol; 2012; 30(6):599-609. PubMed ID: 23068147
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary cryptococcosis.
Jarvis JN; Harrison TS
Semin Respir Crit Care Med; 2008 Apr; 29(2):141-50. PubMed ID: 18365996
[TBL] [Abstract][Full Text] [Related]
11. Cryptococcal meningitis with an antecedent cutaneous Cryptococcal lesion.
Tilak R; Prakash P; Nigam C; Tilak V; Gambhir IS; Gulati AK
Dermatol Online J; 2009 Sep; 15(9):12. PubMed ID: 19930999
[TBL] [Abstract][Full Text] [Related]
12. Disseminated cryptococcosis in a patient with AIDS.
Reblin T; Meyer A; Albrecht H; Greten H
Mycoses; 1994; 37(7-8):275-9. PubMed ID: 7739659
[TBL] [Abstract][Full Text] [Related]
13. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii.
Vu K; Gelli A
Med Mycol; 2010 Mar; 48(2):255-62. PubMed ID: 19572230
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
Nishikawa H; Fukuda Y; Mitsuyama J; Tashiro M; Tanaka A; Takazono T; Saijo T; Yamamoto K; Nakamura S; Imamura Y; Miyazaki T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Kohno S; Izumikawa K
J Antimicrob Chemother; 2017 Jun; 72(6):1709-1713. PubMed ID: 28201509
[TBL] [Abstract][Full Text] [Related]
15. Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease.
Nascimento E; Vitali LH; Kress MRVZ; Martinez R
Rev Inst Med Trop Sao Paulo; 2017; 59():e49. PubMed ID: 28793019
[TBL] [Abstract][Full Text] [Related]
16. Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii.
Chen SC; Korman TM; Slavin MA; Marriott D; Byth K; Bak N; Currie BJ; Hajkowicz K; Heath CH; Kidd S; McBride WJ; Meyer W; Murray R; Playford EG; Sorrell TC;
Clin Infect Dis; 2013 Aug; 57(4):543-51. PubMed ID: 23697747
[TBL] [Abstract][Full Text] [Related]
17. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
Chan M; Lye D; Win MK; Chow A; Barkham T
Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
[TBL] [Abstract][Full Text] [Related]
18. Disseminated cryptococcosis in Crohn's disease: a case report.
Chavapradit N; Angkasekwinai N
BMC Infect Dis; 2018 Dec; 18(1):620. PubMed ID: 30514241
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
Schwarz P; Dromer F; Lortholary O; Dannaoui E
Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
[TBL] [Abstract][Full Text] [Related]
20. Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review.
Chen M; Wang X; Yu X; Dai C; Chen D; Yu C; Xu X; Yao D; Yang L; Li Y; Wang L; Huang X
BMC Infect Dis; 2015 Sep; 15():385. PubMed ID: 26395579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
